These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 25559347)

  • 1. Design, synthesis, and biological evaluation of tetrazole analogs of Cl-amidine as protein arginine deiminase inhibitors.
    Subramanian V; Knight JS; Parelkar S; Anguish L; Coonrod SA; Kaplan MJ; Thompson PR
    J Med Chem; 2015 Feb; 58(3):1337-44. PubMed ID: 25559347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and screening of a haloacetamidine containing library to identify PAD4 selective inhibitors.
    Jones JE; Slack JL; Fang P; Zhang X; Subramanian V; Causey CP; Coonrod SA; Guo M; Thompson PR
    ACS Chem Biol; 2012 Jan; 7(1):160-5. PubMed ID: 22004374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein Arginine Deiminases (PADs): Biochemistry and Chemical Biology of Protein Citrullination.
    Mondal S; Thompson PR
    Acc Chem Res; 2019 Mar; 52(3):818-832. PubMed ID: 30844238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substrate specificity and kinetic studies of PADs 1, 3, and 4 identify potent and selective inhibitors of protein arginine deiminase 3.
    Knuckley B; Causey CP; Jones JE; Bhatia M; Dreyton CJ; Osborne TC; Takahara H; Thompson PR
    Biochemistry; 2010 Jun; 49(23):4852-63. PubMed ID: 20469888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors and inactivators of protein arginine deiminase 4: functional and structural characterization.
    Luo Y; Arita K; Bhatia M; Knuckley B; Lee YH; Stallcup MR; Sato M; Thompson PR
    Biochemistry; 2006 Oct; 45(39):11727-36. PubMed ID: 17002273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D-amino acid based protein arginine deiminase inhibitors: Synthesis, pharmacokinetics, and in cellulo efficacy.
    Bicker KL; Anguish L; Chumanevich AA; Cameron MD; Cui X; Witalison E; Subramanian V; Zhang X; Chumanevich AP; Hofseth LJ; Coonrod SA; Thompson PR
    ACS Med Chem Lett; 2012 Oct; 3(12):1081-1085. PubMed ID: 23420624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A fluoroacetamidine-based inactivator of protein arginine deiminase 4: design, synthesis, and in vitro and in vivo evaluation.
    Luo Y; Knuckley B; Lee YH; Stallcup MR; Thompson PR
    J Am Chem Soc; 2006 Feb; 128(4):1092-3. PubMed ID: 16433522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structures of human peptidylarginine deiminase type III provide insights into substrate recognition and inhibitor design.
    Funabashi K; Sawata M; Nagai A; Akimoto M; Mashimo R; Takahara H; Kizawa K; Thompson PR; Ite K; Kitanishi K; Unno M
    Arch Biochem Biophys; 2021 Sep; 708():108911. PubMed ID: 33971157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The development of N-α-(2-carboxyl)benzoyl-N(5)-(2-fluoro-1-iminoethyl)-l-ornithine amide (o-F-amidine) and N-α-(2-carboxyl)benzoyl-N(5)-(2-chloro-1-iminoethyl)-l-ornithine amide (o-Cl-amidine) as second generation protein arginine deiminase (PAD) inhibitors.
    Causey CP; Jones JE; Slack JL; Kamei D; Jones LE; Subramanian V; Knuckley B; Ebrahimi P; Chumanevich AA; Luo Y; Hashimoto H; Sato M; Hofseth LJ; Thompson PR
    J Med Chem; 2011 Oct; 54(19):6919-35. PubMed ID: 21882827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and use of clickable activity based protein profiling agents for protein arginine deiminase 4.
    Slack JL; Causey CP; Luo Y; Thompson PR
    ACS Chem Biol; 2011 May; 6(5):466-76. PubMed ID: 21265574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-α-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide, a protein arginine deiminase inhibitor, reduces the severity of murine collagen-induced arthritis.
    Willis VC; Gizinski AM; Banda NK; Causey CP; Knuckley B; Cordova KN; Luo Y; Levitt B; Glogowska M; Chandra P; Kulik L; Robinson WH; Arend WP; Thompson PR; Holers VM
    J Immunol; 2011 Apr; 186(7):4396-404. PubMed ID: 21346230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a Selective Inhibitor of Protein Arginine Deiminase 2.
    Muth A; Subramanian V; Beaumont E; Nagar M; Kerry P; McEwan P; Srinath H; Clancy K; Parelkar S; Thompson PR
    J Med Chem; 2017 Apr; 60(7):3198-3211. PubMed ID: 28328217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Halogen Bonding Increases the Potency and Isozyme Selectivity of Protein Arginine Deiminase 1 Inhibitors.
    Mondal S; Gong X; Zhang X; Salinger AJ; Zheng L; Sen S; Weerapana E; Zhang X; Thompson PR
    Angew Chem Int Ed Engl; 2019 Sep; 58(36):12476-12480. PubMed ID: 31276611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of colitis in mice by Cl-amidine: a novel peptidylarginine deiminase inhibitor.
    Chumanevich AA; Causey CP; Knuckley BA; Jones JE; Poudyal D; Chumanevich AP; Davis T; Matesic LE; Thompson PR; Hofseth LJ
    Am J Physiol Gastrointest Liver Physiol; 2011 Jun; 300(6):G929-38. PubMed ID: 21415415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptidomimetics as protein arginine deiminase 4 (PAD4) inhibitors.
    Trabocchi A; Pala N; Krimmelbein I; Menchi G; Guarna A; Sechi M; Dreker T; Scozzafava A; Supuran CT; Carta F
    J Enzyme Inhib Med Chem; 2015 Jun; 30(3):466-71. PubMed ID: 25198885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures.
    Uysal-Onganer P; D'Alessio S; Mortoglou M; Kraev I; Lange S
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The induction of microRNA-16 in colon cancer cells by protein arginine deiminase inhibition causes a p53-dependent cell cycle arrest.
    Cui X; Witalison EE; Chumanevich AP; Chumanevich AA; Poudyal D; Subramanian V; Schetter AJ; Harris CC; Thompson PR; Hofseth LJ
    PLoS One; 2013; 8(1):e53791. PubMed ID: 23308284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein arginine deiminase 4 (PAD4): Current understanding and future therapeutic potential.
    Jones JE; Causey CP; Knuckley B; Slack-Noyes JL; Thompson PR
    Curr Opin Drug Discov Devel; 2009 Sep; 12(5):616-27. PubMed ID: 19736621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of protein arginine deiminases and their efficacy in animal models of multiple sclerosis.
    Sarswat A; Wasilewski E; Chakka SK; Bello AM; Caprariello AV; Muthuramu CM; Stys PK; Dunn SE; Kotra LP
    Bioorg Med Chem; 2017 May; 25(9):2643-2656. PubMed ID: 28341402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Theoretical study of the mechanism of protein arginine deiminase 4 (PAD4) inhibition by F-amidine.
    Li D; Liu C; Lin J
    J Mol Graph Model; 2015 Feb; 55():25-32. PubMed ID: 25424656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.